Deep Tech Startups

Corma builds foundation models that operate as an AI workforce for defensive cybersecurity, working alongside human security teams within their existing security stack. The system is designed to handle defensive cybersecurity tasks and protect organizations against increasingly capable offensive AI threats.

1 investor

Coronal develops plasma arc additive manufacturing technology that melts wire to print near net shapes from difficult alloys for use in extreme environments. It serves energy, aerospace, marine, and defense customers needing advanced manufacturing and material development for high-performance components.

1 investor

Coros Space builds integrated compute platforms that process data onboard spacecraft in orbit, addressing the downlink bottleneck where satellites generate more data than they can transmit to Earth. It develops radiation-tolerant, high-performance computing hardware for space systems and mission-critical applications.

1 investor

Correx develops a medical device system for aortic valve bypass surgery that automates the insertion process, enabling surgeons to perform the procedure on a beating heart without requiring a heart-lung machine. The system is designed for cardiac surgeons performing minimally invasive valve replacement procedures.

1 investor

Cortex Fusion Systems develops nuclear energy technology using ultrafast lasers, including a compact high-repetition-rate fusion source, a hybrid fusion-fission reactor that drives a subcritical fission blanket with fusion neutrons, and a laser-based uranium enrichment process using broadband lasers to produce HALEU and LEU. The company targets grid-scale nuclear energy and fuel production, with technology intended for co-location at industrial sites.

1 investor

Cortical Dynamics develops a brain monitoring device (BARM™) that tracks anesthesia depth in real-time during surgical procedures, particularly for total intravenous anesthesia. The product is designed to improve patient outcomes and reduce the environmental impact of anesthesia administration in operating rooms.

1 investor

Cortirio develops a wearable infrared brain imaging headset for rapid detection of stroke and traumatic brain injury. The device provides portable, on-site diagnosis in under two minutes for clinical use.

1 investor

Cortisonic develops AI hardware based on reservoir computing using arrays of interconnected nanomechanical oscillators (phononic circuits) that process information through vibration and sound. The company targets low-power, high-performance machine learning as an alternative to traditional deep learning models.

1 investor

Cosma develops precise, repeatable and scalable underwater mapping and environmental survey solutions, focused on benthic biodiversity monitoring and subsea obstacle identification. It serves subsea project clients using underwater robotics, navigation, data collection, AI and marine biology expertise, and is based in France.

1 investor

Cosmicport develops small-lift launch vehicles and reusable methalox propulsion systems for deploying satellites to Low Earth Orbit, serving satellite operators and emerging space companies through dedicated and rideshare missions. The company is based near the Kulasekharapatnam launchport in southern India and offers end-to-end services from engine development to launch.

1 investor

COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease. It also provides resources to academic researchers to help translate implantable device concepts into systems tested in first-in-human studies.

1 investor

Hyperweb provides an end-to-end TypeScript ecosystem for building and deploying full-stack blockchain applications, executing smart contracts via a JavaScript VM. Part of the Interchain JavaScript Stack, it targets web3 developers with infrastructure, client tools, and smart contract frameworks for cross-chain development.

1 investor

Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.

1 investor

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS. Its genomics tools serve scientists working in biomarker analysis, gene therapeutics, and clinical diagnostics.

1 investor

CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.

1 investor

Cove GTx develops biodegradable polymeric nanoparticles (PNPs) for non-lipid, non-viral delivery of genetic medicine, aiming to address limitations in delivery efficiency, safety, and manufacturing. The company operates in the genetic medicine and biotechnology field.

1 investor

Coventor builds simulation and modeling software for the semiconductor industry, including platforms for yield optimization, plasma discharge modeling, and process modeling. Its tools serve semiconductor foundries and manufacturers working on technology development and high-volume manufacturing.

1 investor

covolv.ai develops an energy-efficient embedded AI/ML platform and vehicle operating system that enables L2+ to L4 autonomous driving on a single compute unit for vehicle manufacturers. It targets OEMs, Tier-1 suppliers, and technology partners, aiming to make autonomous and driver-assistance features available across mass-market vehicles.

1 investor

COXEM designs and manufactures scanning electron microscopy (SEM) equipment, including tabletop and full-size electron microscopes along with accessories such as ion beam polishers, sputter coaters, and detectors. Its products serve life science and materials science research and analysis.

1 investor

CPP Wind is a professional services and engineering firm specializing in wind energy and renewable energy projects, providing design, engineering, and technical consulting services globally.

1 investor

CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.

1 investor

Crafton Biotechnology develops innovative mRNA-based medicines using proprietary RNA manufacturing, delivery, and synthesis technologies to create safer, scalable therapeutics for infectious diseases and rare conditions. The company focuses on overcoming key challenges in mRNA drug development including immunogenicity, manufacturing complexity, and delivery constraints.

1 investor

Craxel builds Black Forest, a data infrastructure platform that consolidates an organization's fragmented data into a unified, AI-ready knowledge asset and enables real-time contextualized queries and knowledge graphs at scale. It is aimed at large enterprises with massive data challenges and can be deployed on cloud, on-premises, or edge infrastructure with built-in zero trust security.

1 investor

Creatcomm Technology develops WiFi, 5G, and IoT wireless products including 5.8G/60GHz microwave links, WiFi bridges and access points, consumer WiFi6 routers, and cloud-based management systems. It serves telecom operators, wireless video surveillance projects, and SMB coverage needs, with R&D centers in Shanghai and Nanjing and manufacturing in Kunshan.

1 investor